SCOPUS 정보 검색 플랫폼

Oncology

Volumn 62, Issue SUPPL. 1, 2002, Pages 24-28

Current strategies for chemoprevention of hepatocellular carcinoma

(3) Okita, Kiwamu a Sakaida, Isao a Hino, Keisuke a

a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE (Japan)

Author keywords

Antifibrotic agents; Chemoprevention; Fibrosis; Hepatocellular carcinoma; Interferon

Indexed keywords

ALPHA FETOPROTEIN; GLYCYRRHIZIC ACID; INTERFERON; LECTIN; LUFIRONIL; RETINOID; XIAO CHAI HU TANG;

ASIA; CANCER RISK; CHEMOPROPHYLAXIS; CHRONIC HEPATITIS; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; NONHUMAN; PRIORITY JOURNAL; STELLATE CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOPREVENTION; DRUGS, CHINESE HERBAL; FORECASTING; HEPATITIS B; HEPATITIS C; HUMANS; INTERFERONS; LIVER CIRRHOSIS, EXPERIMENTAL; LIVER NEOPLASMS; PYRIDINES; TRETINOIN;

EID: 0036297389 PISSN: 00302414 EISSN: None Source Type: Journal
DOI: 10.1159/000048272 Document Type: Conference Paper

Times cited : (56)

References (18)

1
- 0026343921
- Modulation by butylated hydroxytoluene of liver and bladder carcinogenesis induced by chronic low-level exposure to 2-acetyl-aminofluorene
- (1991) Cancer Res , vol.51 , pp. 6224-6230
- Williams, G.M.¹ Tanaka, T.² Maruyama, H.³ Maeura, Y.⁴ Weisburger, J.H.⁵ Zang, E.⁶

2
- 0026753598
- Retinoids and cancer prevention
- (1992) Annu Rev Nutr , vol.12 , pp. 161-181
- Hill, D.L.¹ Grubbs, C.J.²

3
- 17344369924
- Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C
- (1998) Hepatology , vol.27 , pp. 1394-1402
- Kasahara, A.¹ Hayashi, N.² Mochizuki, K.³ Takayanagi, M.⁴ Yoshioka, K.⁵ Kakumu, S.⁶ Iijima, A.⁷ Urushihara, A.⁸ Kiyosawa, K.⁹ Okuda, M.¹⁰ Hino, K.¹¹ Okita, K.¹²

4
- 0033082888
- Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy
- (1999) Am J Gastroenterol , vol.94 , pp. 489-496
- Sakaida, I.¹ Nagatomi, A.² Hironaka, K.³ Uchida, K.⁴ Okita, K.⁵

5
- 17144455384
- Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy
- (2000) Ann Intern Med , vol.132 , pp. 517-524
- Shiratori, Y.¹ Imazeki, F.² Moriyama, M.³ Yano, M.⁴ Arakawa, Y.⁵ Yokosuka, O.⁶ Kuroki, T.⁷ Nishiguchi, S.⁸ Sata, M.⁹ Yamada, G.¹⁰ Fujiyama, S.¹¹ Yoshida, H.¹² Omata, M.¹³

6
- 0027986913
- Prevention of fibrosis reduces enzyme-altered lesions in the rat liver
- (1994) Carcinogenesis , vol.15 , pp. 2201-2206
- Sakaida, I.¹ Kubota, M.² Kayano, K.³ Takenaka, K.⁴ Mori, K.⁵ Okita, K.⁶

7
- 0030806437
- Prolyl 4-hydroxylase inhibitor (HOE 077) inhibits pig serum-induced rat liver fibrosis by preventing stellate cell activation
- (1997) J Hepatol , vol.27 , pp. 185-192
- Matsumura, Y.¹ Sakaida, I.² Uchida, K.³ Kimura, T.⁴ Ishihara, T.⁵ Okita, K.⁶

8
- 0009608811
- Prevention of hepatocarcinogenesis by fibrosuppression
- Okita K (ed). Springer Verlag, Tokyo
- (2000) Progress of Hepatocellular Carcinoma Treatment , pp. 76-85
- Sakaida, I.¹ Hironaka, K.² Okita, K.³

9
- 0026772813
- Inhibitory effect of dietary iron deficiency on inductions of putative preneoplastic lesions as well as 8-hydroxydeoxyguanosine in DNA and lipid peroxidation in the livers of rats caused by exposure to a choline-deficient -amino acid defined diet
- (1992) Carcinogenesis , vol.13 , pp. 1227-1233
- Yoshiji, H.¹ Nakae, D.² Mizumoto, Y.³ Horiguchi, K.⁴ Tamura, K.⁵ Denda, A.⁶ Tsujii, T.⁷ Konishi, Y.⁸

10
- 0033520109
- Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan
- (1999) Ann Intern Med , vol.131 , pp. 174-181
- Yoshida, H.¹ Shiratori, Y.² Moriyama, M.³ Arakawa, Y.⁴ Ide, T.⁵ Sata, M.⁶ Inoue, O.⁷ Yano, M.⁸ Tanaka, M.⁹ Fujiyama, S.¹⁰ Nishiguchi, S.¹¹ Kuroki, T.¹² Imazeki, F.¹³ Yokosuka, O.¹⁴ Kinoyama, S.¹⁵ Yamada, G.¹⁶ Omata, M.¹⁷

11
- 0028876371
- Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis
- (1995) Lancet , vol.346 , pp. 1051-1055
- Nishiguchi, S.¹ Kuroki, T.² Nakatani, S.³ Morimoto, H.⁴ Takeda, T.⁵ Nakajima, S.⁶ Shiomi, S.⁷ Seki, S.⁸ Kobayashi, K.⁹ Otani, S.¹⁰

12
- 0029113997
- Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9)
- (1995) Cancer , vol.76 , pp. 743-749
- Oka, H.¹ Yamamoto, S.² Kuroki, T.³ Harihara, S.⁴ Marumo, T.⁵ Kim, S.R.⁶ Monna, T.⁷ Kobayashi, K.⁸ Tango, T.⁹

13
- 0032005753
- Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient -amino acid-defined diet
- (1998) J Hepatol , vol.29 , pp. 298-306
- Sakaida, I.¹ Matsumura, Y.² Akiyama, S.³ Hayashi, K.⁴ Ishige, A.⁵ Okita, K.⁶

14
- 5844370499
- Hepatoma Prevention Study Group: Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma
- (1996) N Engl J Med , vol.334 , pp. 1561-1567
- Muto, Y.¹ Moriwaki, H.² Ninomiya, M.³ Adachi, S.⁴ Saito, A.⁵ Takasaki, K.T.⁶ Tanaka, T.⁷ Tsurumi, K.⁸ Okuno, M.⁹ Tomita, E.¹⁰ Nakamura, T.¹¹ Kojima, T.¹²

15
- 0033118925
- Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma
- (1999) N Engl J Med , vol.340 , pp. 1046-1047
- Muto, Y.¹ Moriwaki, H.² Saito, A.³

16
- 0009561356
- Induction to granulocytic differentiation of human promyelocytic leukemia cells (HL-60) by polyprenoic acid (E5166)
- (1986) Bull Yamaguchi Med Sch , vol.33 , pp. 1-7
- Sasaki, K.¹ Murakami, T.² Ogino, S.³ Kawasaki, K.⁴ Okita, K.⁵ Takahashi, M.⁶

17
- 0032032927
- Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: A pilot study
- (1998) Cancer , vol.82 , pp. 827-835
- Ikeda, K.¹ Saitoh, S.² Suzuki, Y.³ Kobayashi, M.⁴ Tsubota, A.⁵ Fukuda, M.⁶ Koida, I.⁷ Arase, Y.⁸ Chayama, K.⁹ Murashima, N.¹⁰ Kumada, H.¹¹

18
- 0036289062
- Long-term treatment of chronic hepatitis C with clycyrrhizin (Stronger Neo-Minophagen C) for preventing liver cirrhosis and hepatocellular carcinoma
- (2002) Oncology , vol.62 , Issue.SUPPL. 1 , pp. 94-100
- Kumada, H.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.